Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cyclin and CBS domain divalent metal cation transport mediator 1 (CNNM1) is a member of the CNNM/ACDP (Ancient conserved domain protein) family, predominantly functioning as a divalent cation (notably magnesium) transporter or regulator within cells[1][2][4][5]. CNNM1 contains four main domains: an extracellular domain, a transmembrane region, a cystathionine-β-synthase (CBS) pair domain, and a cyclic nucleotide-binding homology domain[1][4]. It is primarily expressed in the testis and brain, with lower levels in other tissues, and is implicated in maintenance of magnesium homeostasis, copper binding, and germ cell differentiation[4][5]. Mutations in CNNM1 are associated with inherited diseases such as Jalili syndrome, familial hypomagnesemia, and have also been implicated in cancer development and metastasis, as well as in other disorders[3][4][5]. Its exact transport function remains under study, with evidence suggesting both direct and regulatory roles in cation trafficking[1][4]. No established drugs or mechanism-based interacting therapies are currently described for CNNM1, but the protein is under investigation as a potential therapeutic target in oncology and metabolic disease models.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cyclin and CBS domain divalent metal cation transport mediator 1 (CNNM1).